Christopher P. Thomas
Impact in
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology
- Pharmaceutical Science top 2%
- Advancements in Transdermal Drug Delivery
Papers in
-
- Sphingolipid Metabolism and Signaling 7
- Peroxisome Proliferator-Activated Receptors 3
- Biochemistry 10
- Eicosanoids and Hypertension Pharmacology 9
- Co-authors
- Valerie B. O’Donnell (20 shared papers)Charles M. Heard (11 shared papers)Alan Brash (4 shared papers)Robert C. Murphy (6 shared papers)Victoria J. Hammond (6 shared papers)Peter W. Collins (5 shared papers)Hartmut Kühn (3 shared papers)Diane S. Keeney (1 shared paper)
- Journals
- Journal of Biological Chemistry (5 papers)International Journal of Pharmaceutics (5 papers)Proceedings of the National Academy of Sciences (2 papers)Journal of Pharmacy and Pharmacology (2 papers)Nature Protocols (2 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Christopher P. Thomas
40 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 118
- Biochemistry 236
- Pharmaceutical Science 160
- Dermatology 149
- Biochemistry 91
- Immunology 178
Countries citing papers authored by Christopher P. Thomas
This map shows the geographic impact of Christopher P. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher P. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher P. Thomas more than expected).
Fields of papers citing papers by Christopher P. Thomas
This network shows the impact of papers produced by Christopher P. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher P. Thomas. The network helps show where Christopher P. Thomas may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher P. Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 108 | |
| 2 | 2013 | 98 | |
| 3 | 2009 | 72 | |
| 4 | 2010 | 72 | |
| 5 | 2009 | 66 | |
| 6 | 2013 | 61 | |
| 7 | 2010 | 57 | |
| 8 | 2004 | 52 | |
| 9 | 2006 | 52 | |
| 10 | 2006 | 51 | |
| 11 | 2010 | 47 | |
| 12 | 2011 | 47 | |
| 13 | 2012 | 46 | |
| 14 | 2014 | 37 | |
| 15 | 2021 | 32 | |
| 16 | 2006 | 29 | |
| 17 | 2010 | 26 | |
| 18 | 2013 | 24 | |
| 19 | 2015 | 19 | |
| 20 | 2001 | 16 |
About Christopher P. Thomas
Christopher P. Thomas is a scholar working on Molecular Biology, Biochemistry, Pharmaceutical Science, Immunology and Nutrition and Dietetics, having authored 40 papers that have together received 1.2k indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (9 papers), Sphingolipid Metabolism and Signaling (7 papers), Advancements in Transdermal Drug Delivery (7 papers), Fatty Acid Research and Health (5 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers), Inflammatory mediators and NSAID effects (4 papers), Dermatology and Skin Diseases (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). The work is most often cited by research in Biochemistry (236 citations), Pharmaceutical Science (160 citations), Dermatology (149 citations), Biochemistry (91 citations) and Immunology (178 citations). Christopher P. Thomas has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Valerie B. O’Donnell, Charles M. Heard, Alan Brash, Robert C. Murphy, Victoria J. Hammond, Peter W. Collins, Hartmut Kühn, Diane S. Keeney, Agustí Muñoz‐Garcia and Yu-Xiang Zheng. Their work appears in journals such as Journal of Biological Chemistry, International Journal of Pharmaceutics, Proceedings of the National Academy of Sciences, Journal of Pharmacy and Pharmacology and Nature Protocols.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.